PB1899: DEVELOPMENT AND VALIDATION OF A PREDICTIVE SCORING SYSTEM FOR THE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE RECEIVING FIRST-LINE IMATINIB

por Bektaş, M., Eşkazan, A. E., Tiryaki, T. O., Mullai, R., Elverdi, T., Salihoğlu, A., Tiribelli, M., Ar, M. C., Öngören, S., Başlar, Z., Nalçaci, M., Soysal, T.
Publicado 2022

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

por Salihoglu, A., Elverdi, T., Karadogan, I., Paydas, S., Ozdemir, E., Erdem, G., Karadurmus, N., Akyol, G., Kaynar, L., Yegin, ZA, Sucak, G., Ozkocaman, V., Topcuoglu, P., Ozcan, M., Birtas, E., Goker, H., Baslar, Z., Ferhanoglu, B.
Publicado 2014